Global Contraceptive Drugs and Devices Market Insights, Forecast to 2028

Global Contraceptive Drugs and Devices Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Contraceptive Drugs and Devices Product Introduction
1.2 Market by Type
1.2.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Market by Application
1.3.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Contraceptive Drugs and Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Contraceptive Drugs and Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Contraceptive Drugs and Devices Sales by Region
2.4.1 Global Contraceptive Drugs and Devices Sales by Region (2017-2022)
2.4.2 Global Sales Contraceptive Drugs and Devices by Region (2023-2028)
2.5 Global Contraceptive Drugs and Devices Revenue by Region
2.5.1 Global Contraceptive Drugs and Devices Revenue by Region (2017-2022)
2.5.2 Global Contraceptive Drugs and Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Contraceptive Drugs and Devices Sales by Manufacturers
3.1.1 Global Top Contraceptive Drugs and Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contraceptive Drugs and Devices in 2021
3.2 Global Contraceptive Drugs and Devices Revenue by Manufacturers
3.2.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Contraceptive Drugs and Devices Revenue in 2021
3.3 Global Contraceptive Drugs and Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Contraceptive Drugs and Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Contraceptive Drugs and Devices Sales by Type
4.1.1 Global Contraceptive Drugs and Devices Historical Sales by Type (2017-2022)
4.1.2 Global Contraceptive Drugs and Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
4.2 Global Contraceptive Drugs and Devices Revenue by Type
4.2.1 Global Contraceptive Drugs and Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Contraceptive Drugs and Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
4.3 Global Contraceptive Drugs and Devices Price by Type
4.3.1 Global Contraceptive Drugs and Devices Price by Type (2017-2022)
4.3.2 Global Contraceptive Drugs and Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Contraceptive Drugs and Devices Sales by Application
5.1.1 Global Contraceptive Drugs and Devices Historical Sales by Application (2017-2022)
5.1.2 Global Contraceptive Drugs and Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
5.2 Global Contraceptive Drugs and Devices Revenue by Application
5.2.1 Global Contraceptive Drugs and Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Contraceptive Drugs and Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
5.3 Global Contraceptive Drugs and Devices Price by Application
5.3.1 Global Contraceptive Drugs and Devices Price by Application (2017-2022)
5.3.2 Global Contraceptive Drugs and Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Contraceptive Drugs and Devices Market Size by Type
6.1.1 North America Contraceptive Drugs and Devices Sales by Type (2017-2028)
6.1.2 North America Contraceptive Drugs and Devices Revenue by Type (2017-2028)
6.2 North America Contraceptive Drugs and Devices Market Size by Application
6.2.1 North America Contraceptive Drugs and Devices Sales by Application (2017-2028)
6.2.2 North America Contraceptive Drugs and Devices Revenue by Application (2017-2028)
6.3 North America Contraceptive Drugs and Devices Market Size by Country
6.3.1 North America Contraceptive Drugs and Devices Sales by Country (2017-2028)
6.3.2 North America Contraceptive Drugs and Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Contraceptive Drugs and Devices Market Size by Type
7.1.1 Europe Contraceptive Drugs and Devices Sales by Type (2017-2028)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Type (2017-2028)
7.2 Europe Contraceptive Drugs and Devices Market Size by Application
7.2.1 Europe Contraceptive Drugs and Devices Sales by Application (2017-2028)
7.2.2 Europe Contraceptive Drugs and Devices Revenue by Application (2017-2028)
7.3 Europe Contraceptive Drugs and Devices Market Size by Country
7.3.1 Europe Contraceptive Drugs and Devices Sales by Country (2017-2028)
7.3.2 Europe Contraceptive Drugs and Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Contraceptive Drugs and Devices Market Size by Type
8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Application
8.2.1 Asia Pacific Contraceptive Drugs and Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Contraceptive Drugs and Devices Market Size by Region
8.3.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Contraceptive Drugs and Devices Market Size by Type
9.1.1 Latin America Contraceptive Drugs and Devices Sales by Type (2017-2028)
9.1.2 Latin America Contraceptive Drugs and Devices Revenue by Type (2017-2028)
9.2 Latin America Contraceptive Drugs and Devices Market Size by Application
9.2.1 Latin America Contraceptive Drugs and Devices Sales by Application (2017-2028)
9.2.2 Latin America Contraceptive Drugs and Devices Revenue by Application (2017-2028)
9.3 Latin America Contraceptive Drugs and Devices Market Size by Country
9.3.1 Latin America Contraceptive Drugs and Devices Sales by Country (2017-2028)
9.3.2 Latin America Contraceptive Drugs and Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Drugs and Devices Market Size by Type
10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Application
10.2.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country
10.3.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Church & Dwight
11.3.1 Church & Dwight Corporation Information
11.3.2 Church & Dwight Overview
11.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Church & Dwight Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Church & Dwight Recent Developments
11.4 Warmer Chilcott
11.4.1 Warmer Chilcott Corporation Information
11.4.2 Warmer Chilcott Overview
11.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Warmer Chilcott Recent Developments
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Overview
11.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Agile Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 BioSante Pharmaceuticals
11.7.1 BioSante Pharmaceuticals Corporation Information
11.7.2 BioSante Pharmaceuticals Overview
11.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioSante Pharmaceuticals Recent Developments
11.8 Mayer Laboratories
11.8.1 Mayer Laboratories Corporation Information
11.8.2 Mayer Laboratories Overview
11.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mayer Laboratories Recent Developments
11.9 Pantarhei Bioscience
11.9.1 Pantarhei Bioscience Corporation Information
11.9.2 Pantarhei Bioscience Overview
11.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pantarhei Bioscience Recent Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Overview
11.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Contraceptive Drugs and Devices Industry Chain Analysis
12.2 Contraceptive Drugs and Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptive Drugs and Devices Production Mode & Process
12.4 Contraceptive Drugs and Devices Sales and Marketing
12.4.1 Contraceptive Drugs and Devices Sales Channels
12.4.2 Contraceptive Drugs and Devices Distributors
12.5 Contraceptive Drugs and Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Contraceptive Drugs and Devices Industry Trends
13.2 Contraceptive Drugs and Devices Market Drivers
13.3 Contraceptive Drugs and Devices Market Challenges
13.4 Contraceptive Drugs and Devices Market Restraints
14 Key Findings in The Global Contraceptive Drugs and Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Contraceptive Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Vaginal
Table 4. Major Manufacturers of Injectable Contraceptive Drugs
Table 5. Major Manufacturers of Male/Female Contraceptive Devices
Table 6. Global Contraceptive Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Contraceptive Drugs and Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Contraceptive Drugs and Devices Sales by Region (2017-2022) & (K Units)
Table 9. Global Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)
Table 10. Global Contraceptive Drugs and Devices Sales by Region (2023-2028) & (K Units)
Table 11. Global Contraceptive Drugs and Devices Sales Market Share by Region (2023-2028)
Table 12. Global Contraceptive Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2017-2022)
Table 14. Global Contraceptive Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2023-2028)
Table 16. Global Contraceptive Drugs and Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Contraceptive Drugs and Devices Sales Share by Manufacturers (2017-2022)
Table 18. Global Contraceptive Drugs and Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2017-2022)
Table 20. Contraceptive Drugs and Devices Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Contraceptive Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2021)
Table 23. Contraceptive Drugs and Devices Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Contraceptive Drugs and Devices Product Offered
Table 25. Date of Manufacturers Enter into Contraceptive Drugs and Devices Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 28. Global Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 29. Global Contraceptive Drugs and Devices Sales Share by Type (2017-2022)
Table 30. Global Contraceptive Drugs and Devices Sales Share by Type (2023-2028)
Table 31. Global Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Contraceptive Drugs and Devices Revenue Share by Type (2017-2022)
Table 34. Global Contraceptive Drugs and Devices Revenue Share by Type (2023-2028)
Table 35. Contraceptive Drugs and Devices Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Contraceptive Drugs and Devices Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 38. Global Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 39. Global Contraceptive Drugs and Devices Sales Share by Application (2017-2022)
Table 40. Global Contraceptive Drugs and Devices Sales Share by Application (2023-2028)
Table 41. Global Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Contraceptive Drugs and Devices Revenue Share by Application (2017-2022)
Table 44. Global Contraceptive Drugs and Devices Revenue Share by Application (2023-2028)
Table 45. Contraceptive Drugs and Devices Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Contraceptive Drugs and Devices Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 48. North America Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 49. North America Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 52. North America Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 53. North America Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 56. North America Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 57. North America Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 60. Europe Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 61. Europe Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 64. Europe Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 65. Europe Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 68. Europe Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 69. Europe Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 107. Bayer Healthcare Corporation Information
Table 108. Bayer Healthcare Description and Major Businesses
Table 109. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Bayer Healthcare Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Healthcare Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Merck Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Church & Dwight Corporation Information
Table 118. Church & Dwight Description and Major Businesses
Table 119. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Church & Dwight Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Church & Dwight Recent Developments
Table 122. Warmer Chilcott Corporation Information
Table 123. Warmer Chilcott Description and Major Businesses
Table 124. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Warmer Chilcott Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Warmer Chilcott Recent Developments
Table 127. Agile Therapeutics Corporation Information
Table 128. Agile Therapeutics Description and Major Businesses
Table 129. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Agile Therapeutics Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Agile Therapeutics Recent Developments
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Major Businesses
Table 134. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Pfizer Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Pfizer Recent Developments
Table 137. BioSante Pharmaceuticals Corporation Information
Table 138. BioSante Pharmaceuticals Description and Major Businesses
Table 139. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. BioSante Pharmaceuticals Recent Developments
Table 142. Mayer Laboratories Corporation Information
Table 143. Mayer Laboratories Description and Major Businesses
Table 144. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Mayer Laboratories Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mayer Laboratories Recent Developments
Table 147. Pantarhei Bioscience Corporation Information
Table 148. Pantarhei Bioscience Description and Major Businesses
Table 149. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Pantarhei Bioscience Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Pantarhei Bioscience Recent Developments
Table 152. Teva Pharmaceutical Industries Corporation Information
Table 153. Teva Pharmaceutical Industries Description and Major Businesses
Table 154. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Teva Pharmaceutical Industries Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Contraceptive Drugs and Devices Distributors List
Table 160. Contraceptive Drugs and Devices Customers List
Table 161. Contraceptive Drugs and Devices Market Trends
Table 162. Contraceptive Drugs and Devices Market Drivers
Table 163. Contraceptive Drugs and Devices Market Challenges
Table 164. Contraceptive Drugs and Devices Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptive Drugs and Devices Product Picture
Figure 3. Global Contraceptive Drugs and Devices Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Vaginal Product Picture
Figure 5. Injectable Contraceptive Drugs Product Picture
Figure 6. Male/Female Contraceptive Devices Product Picture
Figure 7. Global Contraceptive Drugs and Devices Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Pharmacies
Figure 10. Others
Figure 11. Contraceptive Drugs and Devices Report Years Considered
Figure 12. Global Contraceptive Drugs and Devices Sales 2017-2028 (K Units)
Figure 13. Global Contraceptive Drugs and Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Contraceptive Drugs and Devices Revenue 2017-2028 (US$ Million)
Figure 15. Global Contraceptive Drugs and Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)
Figure 17. Global Contraceptive Drugs and Devices Sales Market Share by Region (2023-2028)
Figure 18. North America Contraceptive Drugs and Devices Sales YoY (2017-2028) & (K Units)
Figure 19. North America Contraceptive Drugs and Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Contraceptive Drugs and Devices Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Contraceptive Drugs and Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Contraceptive Drugs and Devices Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Contraceptive Drugs and Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Contraceptive Drugs and Devices Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Contraceptive Drugs and Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Contraceptive Drugs and Devices Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Contraceptive Drugs and Devices Revenue YoY (2017-2028) & (US$ Million)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs